hallmarks of cancer
cancer therapy Immunotherapy
novel cancer theranostic approaches
novel personalized cancer therapeutic approach
boundaries of cancer research
novel theranostics
carbohydrate recognition
active therapy
therapeutic potential
theranostic potential of tumor
novel immunogenic moiety
optimized antibodies
potent targeting
design
polyclonal xeno-autoantibodies response
associated carbohydrate antigens
low affinity of antibodies
dietary sugar antigen
red meat-derived carbohydrate antigen
diverse cell surface glycoconjugates
altered cell surface glycosylation
refined tumor cells
fundamental new concepts
innovative interdisciplinary approach
promising new clinical tools
foreign non-human sugar
important alternative
glyco-engineering
immunology
basic understanding
conventional treatment regimes
nanotechnology
carbohydrates poor immunogenicity
cutting-edge technologies
reprogramming
self
glycosciences
passive
key
specificity
potency
proposal
universal leading cause of death
screen
sweet aim
groundbreaking achievements
arms platform
immune system
Selective glycoimmuno
chronic inflammation-mediated diseases
SweetAim
moieties
primary objective
carcinomas
discovery line